| Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial R Ruslami, AR Ganiem, S Dian, L Apriani, TH Achmad, AJ van der Ven, ... The Lancet infectious diseases 13 (1), 27-35, 2013 | 400 | 2013 |
| Improving the microbiological diagnosis of tuberculous meningitis: a prospective, international, multicentre comparison of conventional and modified Ziehl–Neelsen stain … AD Heemskerk, J Donovan, S Marais, L Chaidir, VTM Dung, CM Centner, ... Journal of Infection 77 (6), 509-515, 2018 | 93 | 2018 |
| Pharmacokinetic/pharmacodynamic analysis of an intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis L Te Brake, S Dian, AR Ganiem, C Ruesen, D Burger, R Donders, ... International journal of antimicrobial agents 45 (5), 496-503, 2015 | 93 | 2015 |
| Comparison of real time IS 6110-PCR, microscopy, and culture for diagnosis of tuberculous meningitis in a cohort of adult patients in Indonesia L Chaidir, AR Ganiem, A Vander Zanden, S Muhsinin, T Kusumaningrum, ... PLoS One 7 (12), e52001, 2012 | 87 | 2012 |
| Cerebral tryptophan metabolism and outcome of tuberculous meningitis: an observational cohort study A van Laarhoven, S Dian, R Aguirre-Gamboa, J Avila-Pacheco, ... The Lancet Infectious Diseases 18 (5), 526-535, 2018 | 84 | 2018 |
| Double-blind, randomized, placebo-controlled phase II dose-finding study to evaluate high-dose rifampin for tuberculous meningitis S Dian, V Yunivita, AR Ganiem, T Pramaesya, L Chaidir, K Wahyudi, ... Antimicrobial agents and chemotherapy 62 (12), 10.1128/aac. 01014-18, 2018 | 72 | 2018 |
| Pharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients V Yunivita, S Dian, AR Ganiem, E Hayati, TH Achmad, AP Dewi, M Teulen, ... International journal of antimicrobial agents 48 (4), 415-421, 2016 | 69 | 2016 |
| Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculous meningitis trials EM Svensson, S Dian, L Te Brake, AR Ganiem, V Yunivita, ... Clinical Infectious Diseases 71 (8), 1817-1823, 2020 | 62 | 2020 |
| Pediatric tuberculous meningitis: model‐based approach to determining optimal doses of the anti‐tuberculosis drugs rifampin and levofloxacin for children RM Savic, R Ruslami, JE Hibma, A Hesseling, G Ramachandran, ... Clinical Pharmacology & Therapeutics 98 (6), 622-629, 2015 | 61 | 2015 |
| The effect of HIV infection on adult meningitis in Indonesia: a prospective cohort study AR Ganiem, I Parwati, R Wisaksana, A van der Zanden, D van de Beek, ... Aids 23 (17), 2309-2316, 2009 | 59 | 2009 |
| Asymptomatic cryptococcal antigenemia is associated with mortality among HIV‐positive patients in Indonesia AR Ganiem, AR Indrati, R Wisaksana, H Meijerink, A van der Ven, ... Journal of the International AIDS Society 17 (1), 18821, 2014 | 57 | 2014 |
| Brain MRI findings in relation to clinical characteristics and outcome of tuberculous meningitis S Dian, R Hermawan, A van Laarhoven, S Immaculata, TH Achmad, ... PLoS One 15 (11), e0241974, 2020 | 47 | 2020 |
| Microbiological diagnosis of adult tuberculous meningitis in a ten-year cohort in Indonesia L Chaidir, J Annisa, S Dian, I Parwati, A Alisjahbana, F Purnama, ... Diagnostic microbiology and infectious disease 91 (1), 42-46, 2018 | 42 | 2018 |
| Cerebral toxoplasmosis mimicking subacute meningitis in HIV-infected patients; a cohort study from Indonesia AR Ganiem, S Dian, A Indriati, L Chaidir, R Wisaksana, P Sturm, ... PLoS neglected tropical diseases 7 (1), e1994, 2013 | 40 | 2013 |
| Xpert MTB/RIF ultra for the diagnosis of tuberculous meningitis: a small step forward J Donovan, FV Cresswell, NTT Thuong, DR Boulware, GE Thwaites, ... Clinical Infectious Diseases 71 (8), 2002-2005, 2020 | 37 | 2020 |
| Presentation, etiology, and outcome of brain infections in an Indonesian hospital: A cohort study D Imran, R Estiasari, K Maharani, Sucipto, DC Lestari, RE Yunus, ... Neurology: Clinical Practice 8 (5), 379-388, 2018 | 33 | 2018 |
| Immune cell characteristics and cytokine responses in adult HIV-negative tuberculous meningitis: an observational cohort study A van Laarhoven, S Dian, S van Dorp, F Purnama, VACM Koeken, ... Scientific reports 9 (1), 884, 2019 | 30 | 2019 |
| Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis R Ruslami, F Gafar, V Yunivita, I Parwati, AR Ganiem, RE Aarnoutse, ... Archives of disease in childhood 107 (1), 70-77, 2022 | 26 | 2022 |
| CryptoDex: a randomised, double-blind, placebo-controlled phase III trial of adjunctive dexamethasone in HIV-infected adults with cryptococcal meningitis: study protocol for a … J Day, D Imran, AR Ganiem, N Tjahjani, R Wahyuningsih, R Adawiyah, ... Trials 15, 1-28, 2014 | 26 | 2014 |
| Central nervous system tuberculosis S Dian, AR Ganiem, A van Laarhoven Current opinion in neurology 34 (3), 396-402, 2021 | 25 | 2021 |
Sofiati DianFaculty of Medicine Universitas PadjadjaranVerified email at unpad.ac.id
